Oct-4 transcription factor is initially active as a maternal factor in the oocyte but remains active in embryos throughout the preimplantation period. Oct-4 expression is associated with an undifferentiated phenotype and tumors. Gene knockdown of Oct-4 promotes differentiation, thereby demonstrating a role for these factors in human embryonic stem cell self-renewal. Oct-4 can form a heterodimer with Sox2, so that these two proteins bind DNA together.
Mouse embryos that are Oct-4-deficient or have low expression levels of Oct-4 fail to form the inner cell mass, lose pluripotency and differentiate into trophectoderm. Therefore, the level of Oct-4 expression in mice is vital for regulating pluripotency and early cell differentiation since one of its main functions is to keep the embryo from differentiating.
Oct-4 has been implicated in tumorigenesis of adult germ cells. Ectopic expression of the factor in adult mice has been found to cause the formation of dysplastic lesions of the skin and intestine. The intestinal dysplasia resulted from an increase in progenitor cell population and the upregulation of β-catenin transcription through the inhibition of cellular differentiation.
In 2000, Niwa et al. used conditional expression and repression in murine embryonic stem (ES) cells to determine requirements for Oct-4 in the maintenance of developmental potency. Although transcriptional determination has usually been considered as a binary on-off control system, they found that the precise level of Oct-4 governs 3 distinct fates of ES cells. A less-than-2-fold increase in expression causes differentiation into primitive endoderm and mesoderm. In contrast, repression of Oct-4 induces loss of pluripotency and dedifferentiation to trophectoderm. Thus, a critical amount of Oct-4 is required to sustain stem cell self-renewal, and up- or down regulation induces divergent developmental programs. Niwa et al. suggested that their findings established a role for Oct-4 as a master regulator of pluripotency that controls lineage commitment and illustrated the sophistication of critical transcriptional regulators and the consequent importance of quantitative analyzes.
The transcription factors Oct-4, Sox2 and Nanog are capable of inducing the expression of each other, and are essential for maintaining the self-renewing undifferentiated state of the inner cell mass of the blastocyst, as well as in embryonic stem cells (which are cell lines derived from the inner cell mass).
Oct-4 is one of the transcription factors used to create induced pluripotent stem cells, together with Sox2, Klf4 and often c-Myc in mouse, demonstrating its capacity to induce an embryonic stem cell-like state. It was later deterimined that only two of these four factors, Oct4 and Klf4 were sufficient to reprogram mouse adult neural stem cells. Finally it was shown that a single factor, Oct-4 was sufficient for this transformation.
In in-vitro experiments of murine Embryonic Stem Cells, Oct-4 has often been used as a marker of stemness, as differentiated cells show reduced expression of this marker.
Oct3/4 can both repress and activate the Rex1 promoter. In cells that already express high level of Oct3/4, exogenously transfected Oct3/4 will lead to the repression of Rex1. However, in cells that are not actively expressing Oct3/4, an exogenous transfection of Oct3/4 will lead to the activation of Rex1. This implies a dual regulatory ability of Oct3/4 on Rex1. At low levels of the Oct3/4 protein, the Rex1 promoter is activated, while at high levels of the Oct3/4 protein, the Rex1 promoter is repressed.
Several studies suggest a role for Oct-4 in sustaining self-renewal capacity of adult somatic stem cells (i.e. stem cells from epithelium, bone marrow, liver, etc.). Other scientists have produced evidence to the contrary, and dismiss those studies as artifacts of in vitro culture, or interpreting background noise as signal, and warn about Oct-4 pseudogenes giving false detection of Oct-4 expression. Oct-4 has also been implicated as a marker of cancer stem cells.
^ abNiwa H, Miyazaki J, Smith AG (April 2000). "Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells". Nat. Genet.24 (4): 372–6. doi:10.1038/74199. PMID10742100.
Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE (February 2005). "Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis". Carcinogenesis26 (2): 495–502. doi:10.1093/carcin/bgh321. PMID15513931.
^Zangrossi S, Marabese M, Broggini M, et al. (July 2007). "Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker". Stem Cells25 (7): 1675–80. doi:10.1634/stemcells.2006-0611. PMID17379765.
Lamoury F, Croitoru-Lamoury J, Brew B (2006). "Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1". Cytotherapy8 (3): 228–42. doi:10.1080/14653240600735875. PMID16793732.
Hough S, Clements I, Welch P, Wiederholt K (2006). "Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog". Stem Cells24 (6): 1467–75. doi:10.1634/stemcells.2005-0475. PMID16456133.
Feldman N, Gerson A, Fang J et al. (2006). "G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis". Nat. Cell Biol.8 (2): 188–94. doi:10.1038/ncb1353. PMID16415856.
Gerrard L, Zhao D, Clark A, Cui W (2005). "Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency". Stem Cells23 (1): 124–33. doi:10.1634/stemcells.2004-0102. PMID15625129.
Crouau-Roy B, Amadou C, Bouissou C, et al. (1994). "Localization of the OTF3 gene within the human MHC class I region by physical and meiotic mapping". Genomics21 (1): 241–3. doi:10.1006/geno.1994.1249. PMID8088794.
Guillaudeux T, Mattei MG, Depetris D, et al. (1993). "In situ hybridization localizes the human OTF3 to chromosome 6p21.3→p22 and OTF3L to 12p13". Cytogenet. Cell Genet.63 (4): 212–4. doi:10.1159/000133537. PMID8500351.
Abdel-Rahman B, Fiddler M, Rappolee D, Pergament E (1996). "Expression of transcription regulating genes in human preimplantation embryos". Hum. Reprod.10 (10): 2787–92. PMID8567814.
Hillier LD, Lennon G, Becker M, et al. (1997). "Generation and analysis of 280,000 human expressed sequence tags". Genome Res.6 (9): 807–28. doi:10.1101/gr.6.9.807. PMID8889549.
Inamoto S, Segil N, Pan ZQ, et al. (1997). "The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors". J. Biol. Chem.272 (47): 29852–8. doi:10.1074/jbc.272.47.29852. PMID9368058.
Nichols J, Zevnik B, Anastassiadis K, et al. (1998). "Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4". Cell95 (3): 379–91. doi:10.1016/S0092-8674(00)81769-9. PMID9814708.
Gonzalez MI, Robins DM (2001). "Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1". J. Biol. Chem.276 (9): 6420–8. doi:10.1074/jbc.M008689200. PMID11096094.
Butteroni C, De Felici M, Schöler HR, Pesce M (2001). "Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins". J. Mol. Biol.304 (4): 529–40. doi:10.1006/jmbi.2000.4238. PMID11099378.
Rajpert-De Meyts E, Hanstein R, Jørgensen N, et al. (2004). "Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads". Hum. Reprod.19 (6): 1338–44. doi:10.1093/humrep/deh265. PMID15105401.
Matin MM, Walsh JR, Gokhale PJ, et al. (2005). "Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells". Stem Cells22 (5): 659–68. doi:10.1634/stemcells.22-5-659. PMID15342930.
Baal N, Reisinger K, Jahr H, et al. (2005). "Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood". Thrombosis and Haemostasis92 (4): 767–75. doi:10.1160/TH04-02-0079. PMID15467907.